Sanofi-aventis Forms Strategic Research Alliance With California Institute of Technology

Sanofi-aventis has signed a strategic research alliance agreement with the California Institute of Technology (Caltech) in Pasadena, CA.

The goal of the research collaboration, which will be known as the ‘Sanofi-aventis Bioengineering Research Program at the California Institute of Technology’ (SABER), is to advance knowledge in the area of human health through basic and applied biology research and to promote scientific exchange between Caltech and Sanofi-aventis.

Marc Cluzel, executive vice president of R&D at Sanofi-aventis, said: “This strategic research alliance should significantly complement our research technologies and is a renewed example to partnership with best sciences.”

The research program will provide financial support for several core facilities for up to 5 years, including the Kavli Nanosciences Institute, the Molecular Observatory and the Biological Imaging Center, all located at Caltech. It will also provide flexible financial support to individual Caltech scientists, via bioengineering annual awards (BEA’s), to accelerate innovative research projects.

Stephen Mayo, vice provost of Caltech and bren professor of biology and chemistry, said: “We are pleased to share our expertise and commitment to research with sanofi-aventis. We believe this collaboration will lead to discoveries that one day may improve human health.”